This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluorophenyl group, makes it valuable in the development of drugs with enhanced metabolic stability and bioavailability. It is often employed in the production of compounds targeting central nervous system disorders, cardiovascular diseases, and other therapeutic areas. Additionally, its unique fluorinated structure contributes to the creation of molecules with improved binding affinity and selectivity for specific biological targets. The compound is also explored in medicinal chemistry research for the design of novel drug candidates with optimized pharmacokinetic properties.